Keywords: s-p/merck, co, pull, loratadine/montelukast, combo, nda, drug

S-P/Merck & Co pull loratadine/montelukast combo NDA

Article | 07 July 2008

Print This

US drug majors Schering-Plough and and Merck & Co have withdrawn their New Drug Application for the loratadine/montelukast combination tablet ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in